The EOF has recalled three medications due to various safety and quality concerns.
The Greek National Organization for Medicines (EOF) has issued a recall for three medications due to different issues impacting their safety and quality. The first medication is FLAGYL 500 mg/cap, which was found to contain a foreign body in one of its packages, raising concerns about contamination that could affect patient safety.
The second drug involved in the recall is Rivaroxaban Tablets 20mg from batch number 8211799, which failed to meet specifications during an impurity control test. This suggests potential risks that could compromise the drug's efficacy in treating conditions like blood clots.
Lastly, the recall includes SULBENIN F.C. TAB 5MG/TAB (with batch number 25A150), which was incorrectly recorded regarding its expiration date in the EOF's electronic platform. It is important to note that this batch does not have any quality issues, but the misinformation could lead to confusion regarding the medication's safety for consumers. The EOF’s swift action emphasizes their commitment to maintaining public health standards and ensuring the safety of pharmaceutical products in Greece.
